Zevra Therapeutics, Inc. ( ZVRA) - Key Metrics
ZVRA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.67 | $0.15 | $0.29 | $0.28 |
| 2026Q1 | $0.62 | $0.65 | $0.11 | $0.10 |
| 2025Q4 | $0.62 | $0.22 | $0.10 | $0.10 |
| 2025Q3 | $0.47 | -$0.01 | $0.08 | $0.07 |
| 2025Q2 | $0.47 | $1.36 | -$0.07 | -$0.07 |
ZVRA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 25.61 |
| 2026Q1 | 0% | 3.76 |
| 2025Q4 | 0% | 10.67 |
| 2025Q3 | 0% | -245.10 |
| 2025Q2 | 0% | 1.62 |
ZVRA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.98% | 0% |
| 2026Q1 | 1.12% | 0% |
| 2025Q4 | 1.12% | 0% |
| 2025Q3 | 0.78% | 0% |
| 2025Q2 | -0.79% | 0% |
ZVRA
Price: $11.89
52 week price:
Earnings Per Share: 0.93 USD
P/E Ratio: 12.19
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 673.4 million